Clinical Trial Update: Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial update evaluating a conditioning regimen of Helical Tomotherapy with fludarabine phosphate and melphalan followed by allogeneic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)
• Helical Tomotherapy
• Melphalan (Melphalan)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-05-10